Naslov
Inflammatory bowel disease does not alter the clinical features and the management of acute pancreatitis: A prospective, multicentre, exact- matched cohort analysis

Autori
Dohos, Dóraa ; Farkas, Nellia ; Váradi, Alexa ; Erőss, Bálinta ; Párniczky, Andreaa ; Szentesi, Andreaa ; Hegyi, Pétera ; Sarlós, Patríciaf ; Czakó, László ; Boros, Eszter ; Hussein, Tamás ; Márta, Katalin ; Borka, Katalin ; Doros, Attila ; Hosszúfalusi, Nóra ; Zubek, László ; Molnár, Zsolt ; Váncsa, Szilárd ; Nagy, Rita ; Bunduc, Stefania ; Földi, Mária ; Faluhelyi, Nándor ; Farkas, Orsolya ; Vincze, Áron ; Kui, Balázs ; Izbéki, Ferenc ; Hamvas, József ; Papp, Mária ; Varga, Márta ; Török, Imola ; Mickevicius, Artautas ; Maldonado, Elena Ramirez ; Sallinen, Ville ; Ince, Ali Tüzün ; Galeev, Shamil ; Poropat, Goran ; Štimac, Davor ; Litvin, Andrey ; Ozola-Zalite, Imanta ; Pukitis, Aldis ; Zadorozhna, Kristina ; Gyökeres, Tibor

Kolaboracija
Hungarian Pancreatic Study Group

Izvornik
Pancreatology (1424-3903) 22 (2022), 8; 1071-1078

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Acute pancreatitis ; Inflammatory bowel disease ; Antibiotics ; Disease management

Sažetak
Objective and aims Acute pancreatitis in inflammatory bowel disease occurs mainly as an extraintestinal manifestation or a side effect of medications. We aimed to investigate the prognostic factors and severity indicators of acute pancreatitis and the treatment of patients with both diseases. Design We performed a matched case-control registry analysis of a multicentre, prospective, international acute pancreatitis registry. Patients with both diseases were matched to patients with acute pancreatitis only in a 1:3 ratio by age and gender. Subgroup analyses were also carried out based on disease type, activity, and treatment of inflammatory bowel disease. Results No difference in prognostic factors (laboratory parameters, bedside index of severity in acute pancreatitis, imaging results) and outcomes of acute pancreatitis (length of hospitalization, severity, and local or systemic complications) were detected between groups. Significantly lower analgesic use was observed in the inflammatory bowel disease population. Antibiotic use during acute pancreatitis was significantly more common in the immunosuppressed group than in the non- immunosuppressed group (p = 0.017). However, none of the prognostic parameters or the severity indicators showed a significant difference between any subgroup of patients with inflammatory bowel disease. Conclusion No significant differences in the prognosis and severity of acute pancreatitis could be detected between patients with both diseases and with pancreatitis only. The need for different acute pancreatitis management is not justified in the coexistence of inflammatory bowel disease, and antibiotic overuse should be avoided.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA